logo
Select company
Select metric
6.68%Debt to Assets Ratio
VS
Market
71
Sector
62
Industry
81
History
40
$ 4.3Close
$ 1.96 - $ 4.3 52-Week Range
Ticker Information

Ticker

IMDX

Company Name

INSIGHT MOLECULAR DIAGNOSTICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

INSIGHT MOLECULAR DIAGNOSTICS INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMDX - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 50.52M$ 3.37M6.68%
3/31/2025$ 60.36M$ 3.48M5.76%
12/31/2024$ 35.08M$ 3.66M10.44%
9/30/2024$ 70.22M$ 3.99M5.68%
6/30/2024$ 74.72M$ 3.67M4.91%
3/31/2024$ 70.97M$ 3.33M4.7%
12/31/2023$ 74.89M$ 2.87M3.83%
9/30/2023$ 81.59M$ 3.07M3.77%
6/30/2023$ 87.54M$ 3.13M3.58%
3/31/2023$ 82.8M$ 3.33M4.02%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INSIGHT MOLECULAR DIAGNOSTICS INC's latest trailing twelve months (TTM) Debt to Assets stands at 14.63%.
  • Over the past 5 years, INSIGHT MOLECULAR DIAGNOSTICS INC's average Debt to Assets has been 5.65%.
  • The median Debt to Assets for INSIGHT MOLECULAR DIAGNOSTICS INC during this period was 3.92%
  • INSIGHT MOLECULAR DIAGNOSTICS INC reached its highest Debt to Assets over the past 5 years at 15.58%.
  • The lowest Debt to Assets recorded by INSIGHT MOLECULAR DIAGNOSTICS INC in the same timeframe 2.39%

INSIGHT MOLECULAR DIAGNOSTICS INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
VNRX : VOLITIONRX LTD 125.73%ARMP : ARMATA PHARMACEUTICALS INC 178.18%CBUS : CIBUS INC 72.76%PYXS : PYXIS ONCOLOGY INC 15.8%NTRB : NUTRIBAND INC 2.66%PRPH : PROPHASE LABS INC 18.71%LUCD : LUCID DIAGNOSTICS INC 71.25%PSTV : PLUS THERAPEUTICS INC 0.29%BNBX : APPLIED DNA SCIENCES INC 3.37%ALGS : ALIGOS THERAPEUTICS INC 5.11%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for INSIGHT MOLECULAR DIAGNOSTICS INC is calculated as follows: Debt [ $ 8.45M ] / Assets [ $ 57.78M ]
(=) Debt to Assets [ 14.63% ]

IMDX - Debt to Assets Ratio, Last 5 years

2.39%

Minimum

Sep 30, 2022

15.58%

Maximum

Dec 31, 2020

5.65%

Average

3.92%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.34% with a standard deviation of 24.52%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.34%
median21.09%
std24.52%